Events / Journal Club

Journal Club

7:00 a.m.-8:00 a.m.
Zoom, 660 S. Euclid Ave., St. Louis, MO 63110

“Efficacy and safety of 48 weeks of guselkumab for patients with Crohn’s disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial”

Matthew Vincent, MBBS

&

“Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial”

Qianli Wang, MD, PhD

 

Please Contact Beth Buschard-Steiger (bbuscha@wustl.edu) for Zoom Details